Cystagon (Cysteamine Bitartrate) Capsules

Cystagon (cysteamine bitartrate) is an oral cystine-depleting agent indicated for the management of nephropathic cystinosis in adults and children — a genetic disorder in which cystine accumulates in cells (especially the kidneys) and forms damaging crystals, leading to Fanconi syndrome and progressive kidney failure if untreated.

Cysteamine reacts with cystine inside lysosomes to form a compound the body can transport out of the cell, depleting the abnormal cystine buildup that damages the kidneys and other organs in cystinosis.

• Gastrointestinal ulceration and bleeding have been reported.
• Skin lesions/rashes, including cases requiring dose reduction, have occurred with long-term use.
• Central nervous system effects (somnolence, encephalopathy) reported at high doses.
• Common side effects: nausea, vomiting, unpleasant breath/body odor, loss of appetite, lethargy.

What documents are required to import Cystagon to India?

Cystagon may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a registered physician/nephrologist
• Diagnostic report confirming nephropathic cystinosis
• Patient ID proof (issued by the Government of India, or guardian’s ID for pediatric patients)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription and an import permit, if applicable.

Is Cystagon available in India?

Cystagon is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Indian Pharma Network (IPN) can source Cystagon from reliable channels across the world and facilitate supply to patients, doctors, and hospitals for this long-term therapy.

For Cystagon cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• United States: Approved by the FDA — initial approval 1994.

What is Cystagon used for?

Cystagon treats nephropathic cystinosis by depleting the abnormal cystine buildup that damages the kidneys and other organs.

Who manufactures Cystagon?

Cystagon is manufactured by Mylan Pharmaceuticals Inc. (Viatris).

What is the dosage of Cystagon?

Adults typically take 500 mg four times daily; pediatric dosing is calculated by body surface area. Always follow the treating physician’s regimen.

How much does Cystagon cost in India?

Cost depends on strength, daily dose, and sourcing logistics — share your prescription with IPN for a quote.